# Commission Delegated Directive 2014/3/EU of 18 October 2013 amending, for the purposes of adapting to technical progress, the Annex IV to Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for lead acetate marker for use in stereotactic head frames for use with CT (Computed Tomography) and MRI and in positioning systems for gamma beam and particle therapy equipment (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Annex IV to Directive 2011/65/EU the following point 22 is added:
22.. ‘Lead acetate marker for use in stereotactic head frames for use with CT and MRI and in positioning systems for gamma beam and particle therapy equipment. Expires on 30 June 2021.’

---
Source: https://www.legislation.gov.uk/eudr/2014/3/annex (the official version)
Page: https://openlegislation.uk/eu-directive-2014-3/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.